Q2BI Earns ISO/IEC 27001:2022 Certification for Information Security
As life sciences become increasingly data-driven and technology-enabled, protecting sensitive information is fundamental to how Q-Square Business Intelligence (Q2BI) supports its clients. Q2BI has earned ISO/IEC 27001:2022 certification for its Information Security Management System (ISMS), marking an important milestone in the company’s continued investment in information security.
The certification validates Q2BI’s systematic approach to identifying and managing information security risks while protecting the confidentiality, integrity, and availability of information.
Supporting Secure, Data-Driven Life Sciences Services
Life sciences organizations work with highly sensitive data and increasingly complex collaboration across sponsors, research partners, technology providers, and global teams. As data moves across functions, systems, and organizations, effective information security is essential to maintaining data integrity, operational reliability, and trust.
Q2BI’s certified Information Security Management System covers:
“The provision of data-driven life sciences services, including the design, development, deployment, and management of clinical, analytical, and technology solutions for the pharmaceutical, biotechnology, and healthcare industries.”
For Q2BI’s clients and partners, the certification provides independent validation that information security is managed through established policies, controls, responsibilities, and risk-management processes across the organization.
Strengthening the Foundation Behind Q2BI’s Services
Q2BI supports pharmaceutical, biotechnology, and healthcare organizations through a broad range of data-driven services and technology solutions, including clinical data management, biostatistics, statistical programming, medical writing, data visualization, and technology-enabled clinical solutions. These services require Q2BI teams to work with sensitive clinical, operational, and analytical information throughout the clinical development lifecycle.
ISO/IEC 27001:2022 certification adds another layer of assurance to how Q2BI manages that responsibility. It reflects a company-wide approach to:
Protecting sensitive client and clinical information
Identifying and managing information security risks systematically
Maintaining clear governance, controls, and accountability
Supporting consistent and reliable delivery across Q2BI’s services
Continuously reviewing and improving information security practices
As Q2BI expands its life sciences services and technology capabilities globally, this certification reinforces its commitment to information security and client trust.